General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 471: Replacement of columnar epithelium of respiratory tract to squamous epithelium is termed as what?

A. Hyperplasia
B. Metaplasia (Correct Answer)
C. Hypoplasia
D. Atrophy

Explanation: **Explanation:** The correct answer is **Metaplasia**. **Why Metaplasia is correct:** Metaplasia is a reversible change in which one differentiated cell type (epithelial or mesenchymal) is replaced by another differentiated cell type [1]. It is an adaptive response to chronic irritation. In the respiratory tract, chronic irritation (most commonly from **cigarette smoking**) causes the fragile ciliated columnar epithelium to be replaced by the more rugged **stratified squamous epithelium** [1], [3]. While this new epithelium is more resistant to physical stress, it loses vital functions like mucus secretion and ciliary clearance [1]. **Why the other options are incorrect:** * **Hyperplasia:** Refers to an increase in the *number* of cells in an organ or tissue, usually resulting in increased volume [1]. The cell type remains the same. * **Hypoplasia:** Refers to the incomplete development or underdevelopment of an organ or tissue, resulting in a lower-than-normal number of cells. * **Atrophy:** Refers to a decrease in cell size and number, leading to a reduction in the size of an organ or tissue [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Reversibility:** Metaplasia is reversible if the stimulus (e.g., smoking) is removed [1]. However, if the irritation persists, it can progress to **Dysplasia** and eventually **Neoplasia** (Squamous Cell Carcinoma) [1], [2]. * **Barrett’s Esophagus:** This is the most common example of **Columnar Metaplasia**, where squamous epithelium of the esophagus changes to columnar (intestinal) epithelium due to acid reflux [4]. * **Mechanism:** Metaplasia does not result from a change in the phenotype of an already differentiated cell; instead, it is the result of a **reprogramming of tissue stem cells** [1]. * **Vitamin A Deficiency:** Can also induce squamous metaplasia in the respiratory tract and ducts of glands [1], [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 47-49. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 723. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 91-92. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349.

Question 472: Which of the following is true regarding Turner syndrome?

A. XY chromosomal abnormality
B. Tall stature, small testes
C. Preductal coarctation of aorta (Correct Answer)
D. Presence of testes

Explanation: **Explanation:** Turner Syndrome is the most common sex chromosome abnormality in females, typically characterized by a **45,X karyotype** (monosomy X) or mosaicism. **1. Why Option C is Correct:** Cardiovascular malformations occur in approximately 25–50% of patients with Turner syndrome. The most characteristic lesions are **bicuspid aortic valve** (most common) and **preductal (infantile type) coarctation of the aorta**. The underlying mechanism is thought to be related to lymphatic obstruction during fetal development, which alters hemodynamics in the developing heart. **2. Why Other Options are Incorrect:** * **Option A & D:** Turner syndrome involves females with a missing or structurally abnormal X chromosome. They possess **streak ovaries** (due to accelerated oocyte loss) rather than testes. The presence of Y-chromosomal material or testes would suggest conditions like Swyer syndrome or Mixed Gonadal Genesis. * **Option B:** This description (Tall stature, small firm testes, gynecomastia) is classic for **Klinefelter Syndrome (47,XXY)** [2]. Patients with Turner syndrome characteristically exhibit **short stature** due to the loss of the *SHOX* gene [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Karyotype:** 45,X is the most common (50%), followed by mosaicism (e.g., 45,X/46,XX) and structural abnormalities (isochromosome Xq). * **Clinical Triad:** Short stature, webbed neck (cystic hygroma remnant), and primary amenorrhea [1]. * **Renal Anomaly:** Horseshoe kidney is the most common renal finding. * **Endocrine:** Increased FSH/LH levels (hypergonadotropic hypogonadism) due to ovarian failure. * **Autoimmune:** Increased risk of Hashimoto thyroiditis and Celiac disease. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 175-177. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 174-175.

Question 473: Which of the following is NOT an inherited disorder?

A. Protein S deficiency
B. Factor V Leiden mutation
C. Antiphospholipid antibody syndrome (Correct Answer)
D. Protein C resistance

Explanation: ### Explanation The key to answering this question lies in distinguishing between **congenital (inherited)** and **acquired** hypercoagulable states (thrombophilias) [1]. **Why Antiphospholipid Antibody Syndrome (APS) is the correct answer:** APS is an **acquired** autoimmune hypercoagulable state [2]. It is characterized by the presence of clinical symptoms (venous/arterial thrombosis or pregnancy complications) and specific laboratory markers (Lupus anticoagulant, Anti-cardiolipin antibodies, or Anti-̢2-glycoprotein I). Unlike the other options, it is not caused by a germline genetic mutation passed from parents to offspring, though it may occur secondary to other autoimmune diseases like SLE [2]. **Analysis of Incorrect Options:** * **Factor V Leiden Mutation:** This is the **most common inherited cause** of hypercoagulability [1]. It involves a point mutation (G1691A) in the Factor V gene, making Factor V resistant to inactivation by activated Protein C (APC) [1]. * **Protein C Resistance:** This is a functional description of the inability of Protein C to cleave Factors Va and VIIIa. While it can rarely be acquired, in the context of NEET-PG, it is almost synonymous with **Factor V Leiden**, which is an inherited condition [1]. * **Protein S Deficiency:** This is an **inherited** autosomal dominant disorder. Protein S is a necessary cofactor for Protein C; its deficiency leads to a failure to inactivate Factors Va and VIIIa, resulting in a prothrombotic state. **NEET-PG High-Yield Pearls:** * **Most common inherited thrombophilia:** Factor V Leiden [1]. * **Most common acquired thrombophilia:** Antiphospholipid Antibody Syndrome [2]. * **Paradoxical Lab Finding in APS:** It causes a **prolonged aPTT** *in vitro* (due to interference with phospholipids in the test), but causes **thrombosis** *in vivo* [2]. * **Screening:** If a young patient ( <45 years) presents with recurrent DVT or unusual site thrombosis, always rule out inherited deficiencies first. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 133-134. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 134-135.

Question 474: The process of programmed gene-directed cell death characterized by cell shrinkage, nuclear condensation, and fragmentation is known as?

A. Necrosis
B. Chromatolysis
C. Pyknosis
D. Apoptosis (Correct Answer)

Explanation: **Explanation:** The correct answer is **Apoptosis**. **1. Why Apoptosis is correct:** Apoptosis is a pathway of cell death induced by a tightly regulated intracellular program (**programmed cell death**) [1]. It is an active, energy-dependent process where cells destined to die activate enzymes (caspases) that degrade their own nuclear DNA and proteins [2]. Key morphological hallmarks include **cell shrinkage**, chromatin condensation (the most characteristic feature), and the formation of cytoplasmic blebs and **apoptotic bodies**. Crucially, the plasma membrane remains intact, preventing an inflammatory response [3]. **2. Why other options are incorrect:** * **Necrosis:** Unlike apoptosis, necrosis is always pathological and characterized by cell swelling (oncosis), membrane disruption, and enzymatic digestion of the cell, leading to significant **inflammation**. * **Chromatolysis:** This refers specifically to the dissolution of Nissl bodies in the cell body of a neuron following axonal injury. It is a regenerative effort, not a form of programmed cell death. * **Pyknosis:** While pyknosis (nuclear shrinkage and increased basophilia) is a feature of apoptosis, it is also seen in necrosis. It is a *component* of the process, not the name of the entire programmed pathway. **NEET-PG High-Yield Pearls:** * **Gold Standard Detection:** DNA Laddering on electrophoresis (due to internucleosomal cleavage by endonucleases). * **Marker:** Annexin V (binds to Phosphatidylserine flipped to the outer membrane leaflet). * **Key Enzyme:** Caspases (Cysteine aspartic acid-specific proteases) [2]. * **Mitochondrial Pathway:** Controlled by the Bcl-2 family (Bcl-2/Bcl-xL are anti-apoptotic; Bax/Bak are pro-apoptotic) [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81.

Question 475: If a rare disease with an early onset of symptoms is inherited in a way where males and females are affected equally and only homozygous persons are affected, then the likely mode of inheritance is

A. Autosomal dominant inheritance
B. Autosomal recessive inheritance (Correct Answer)
C. X linked dominant inheritance
D. X linked recessive inheritance

Explanation: ### Explanation The question describes a classic pattern of **Autosomal Recessive (AR) inheritance**. Here is the breakdown of the key features: **1. Why Autosomal Recessive is correct:** * **"Males and females are affected equally":** This indicates the gene is located on an **autosome** (non-sex chromosome), as sex-linked traits typically show a gender bias. * **"Only homozygous persons are affected":** This is the hallmark of recessive inheritance. A single mutant allele (heterozygous) results in a "carrier" state with no clinical symptoms; the disease only manifests when both alleles are mutated (homozygous) [1]. * **"Early onset of symptoms":** AR diseases often involve deficiencies in enzymes (e.g., Inborn Errors of Metabolism), which typically present early in life, unlike Autosomal Dominant conditions which may have a delayed onset [3]. **2. Why other options are incorrect:** * **Autosomal Dominant (AD):** These manifest in **heterozygotes** (only one copy of the mutant gene is needed) [1]. They often involve structural proteins and frequently show a later age of onset (e.g., Huntington’s disease) [4]. * **X-linked Dominant (XLD):** While both sexes are affected, there is a distinct bias: affected males pass the trait to **all** of their daughters and **none** of their sons. * **X-linked Recessive (XLR):** These predominantly affect **males**. Females are typically asymptomatic carriers because they have a second normal X chromosome to compensate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Consanguinity:** AR diseases are more common in offspring of related parents (increases the chance of two carriers meeting) [1]. * **Horizontal Transmission:** AR traits often appear in siblings but not in parents (skipping generations). * **Enzyme vs. Structure:** Remember the rule of thumb—**AR** usually involves **Enzymes** (e.g., PKU, Alkaptonuria, Lysosomal storage diseases), while **AD** usually involves **Structural proteins** (e.g., Marfan syndrome, Achondroplasia) [2], [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 53-54. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 150-151. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 149-150.

Question 476: Foam cells are seen in which of the following conditions?

A. Alport syndrome
B. Niemann-Pick disease
C. Atherosclerosis (Correct Answer)
D. Pneumonia

Explanation: **Explanation:** **Foam cells** are a hallmark of **Atherosclerosis**. They are primarily macrophages (and sometimes smooth muscle cells) that have ingested large amounts of oxidized low-density lipoprotein (LDL) via scavenger receptors. When these cells become overloaded with lipid vacuoles, they take on a "foamy" appearance under the microscope [1], [2]. These cells aggregate in the tunica intima to form the "fatty streak," the earliest visible lesion of atherosclerosis [1]. **Analysis of Options:** * **A. Alport Syndrome:** This is a genetic disorder of Type IV Collagen affecting the glomerular basement membrane. While "foam cells" can occasionally be seen in the interstitium of the kidney in Alport syndrome, they are a non-specific finding of proteinuria and not the primary diagnostic or characteristic feature. * **B. Niemann-Pick Disease:** This lysosomal storage disorder is characterized by **"Sphingomyelinase deficiency."** While the cells are lipid-laden, they are specifically referred to as **"Niemann-Pick cells"** (mulberry-like appearance) rather than the classic foam cells associated with vascular pathology [3]. * **C. Atherosclerosis (Correct):** As explained, the transformation of macrophages into foam cells is the fundamental step in the pathogenesis of atherosclerotic plaques [2], [4]. * **D. Pneumonia:** Typical bacterial pneumonia involves an exudate of neutrophils and fibrin. While "lipid pneumonia" (rare) can show lipid-laden macrophages, it is not a general feature of pneumonia. **High-Yield Clinical Pearls for NEET-PG:** * **Scavenger Receptors (CD36/SR-A):** Unlike LDL receptors, these are not down-regulated by high intracellular cholesterol, allowing macrophages to keep engorging until they become foam cells. * **Xanthomas:** Foam cells are also the primary component of skin xanthomas seen in hyperlipidemic states [3]. * **Leprosy:** In Lepromatous Leprosy, macrophages filled with *M. leprae* are called **Virchow cells** or "lepra cells," which also have a foamy appearance. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 505-506. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Cardiovascular Disease, pp. 268-270. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 73-74. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 504-505.

Question 477: A 28-year-old lactating mother with a history of hepatectomy presents for follow-up. Which of the following cellular adaptations will be seen in this patient?

A. Hypertrophy of the liver and hypertrophy of the breast
B. Hypertrophy and hyperplasia of the liver and hypertrophy of the breast (Correct Answer)
C. Hyperplasia of the liver and hyperplasia of the breast
D. Hyperplasia of the liver and hyperplasia and hypertrophy of the breast

Explanation: ### Explanation This question tests the understanding of cellular adaptations—specifically **Hypertrophy** (increase in cell size) and **Hyperplasia** (increase in cell number)—and how they often occur concurrently in tissues capable of division [1][2]. **1. Why Option B is Correct:** * **Liver (Post-hepatectomy):** The liver has a high regenerative capacity. Following a partial hepatectomy, the remaining hepatocytes enter the cell cycle to restore the functional mass [2]. This process involves **both hyperplasia** (proliferation of mature hepatocytes) and **hypertrophy** (increase in cell size to compensate for lost metabolic function). This is a classic example of *Compensatory Hyperplasia*. * **Breast (Lactation):** During pregnancy and lactation, the breast undergoes physiological adaptation driven by hormones like prolactin and estrogen. While the initial growth during pregnancy involves hyperplasia of the glandular epithelium, the functional state of **lactation** is predominantly characterized by **hypertrophy** of the acinar cells as they increase their protein-synthetic machinery to produce milk [1]. **2. Why Other Options are Incorrect:** * **Option A:** Incorrect because it misses the significant hyperplastic component of liver regeneration. * **Option C:** Incorrect because it ignores the hypertrophic component in both organs. In the lactating breast, the primary change is the enlargement of existing secretory cells (hypertrophy) [1]. * **Option D:** Incorrect because, while the breast undergoes hyperplasia during *pregnancy*, the primary adaptation during the active *lactation* phase (as specified in the stem) is hypertrophy [1]. **3. NEET-PG High-Yield Pearls:** * **Pure Hypertrophy:** Occurs in non-dividing cells (e.g., Cardiac muscle in hypertension, Skeletal muscle in exercise). * **Pure Hyperplasia:** Can be physiological (e.g., hormonal changes in the endometrium) or pathological (e.g., Benign Prostatic Hyperplasia) [1]. * **Liver Regeneration:** It is the only internal organ capable of "compensatory hyperplasia" where the organ returns to its original size without "regrowing" the specific lobes that were removed [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-88. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 108-109.

Question 478: CD95 is a marker of which of the following?

A. Intrinsic pathway of apoptosis
B. Extrinsic pathway of apoptosis (Correct Answer)
C. Necrosis of cell
D. Cellular adaptation

Explanation: **Explanation:** **CD95**, also known as the **Fas receptor**, is a critical surface molecule involved in the **Extrinsic (Death Receptor-initiated) pathway of apoptosis** [1]. 1. **Why Option B is Correct:** The extrinsic pathway is triggered when specific death receptors on the plasma membrane are engaged. CD95 (Fas) binds to its ligand, **FasL** (typically expressed on T-cells) [1]. This binding leads to the recruitment of the adapter protein **FADD** (Fas-associated death domain), which then activates **Caspase-8** (the initiator caspase of this pathway) [1]. This sequence bypasses the mitochondria to directly induce programmed cell death. 2. **Why Other Options are Incorrect:** * **Option A (Intrinsic Pathway):** This pathway is regulated by the **mitochondria** and the Bcl-2 family of proteins [2]. It is triggered by internal cell stress (DNA damage, withdrawal of growth factors) and involves the release of **Cytochrome c** and activation of **Caspase-9** [2]. * **Option C (Necrosis):** Necrosis is an accidental, unregulated form of cell death characterized by cell swelling, membrane rupture, and inflammation. It does not involve specific signaling receptors like CD95 [3]. * **Option D (Cellular Adaptation):** This refers to reversible changes (hypertrophy, hyperplasia, atrophy, metaplasia) in response to environmental changes, not a programmed death mechanism. **High-Yield Clinical Pearls for NEET-PG:** * **Initiator Caspases:** Extrinsic pathway = Caspase 8 & 10; Intrinsic pathway = Caspase 9 [2]. * **Executioner Caspases:** Caspase 3, 6, and 7 (common to both pathways) [2]. * **FLIP Protein:** A viral/cellular protein that inhibits the extrinsic pathway by blocking Caspase-8 activation. * **Autoimmune Lymphoproliferative Syndrome (ALPS):** Caused by mutations in the Fas receptor (CD95) or FasL, leading to defective apoptosis of self-reactive lymphocytes. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 65-67. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 69-71.

Question 479: What is the earliest manifestation of cell injury?

A. Vasoconstriction (Correct Answer)
B. Increased vascular permeability
C. Phagocytosis
D. Apoptosis

Explanation: **Explanation:** The correct answer is **Vasoconstriction**. This question refers to the vascular changes occurring during the **acute inflammatory response**, which is the body's immediate reaction to cell injury. 1. **Why Vasoconstriction is correct:** Immediately following cell injury (especially mechanical or chemical), there is a transient, neurogenic reflex causing **vasoconstriction** of the arterioles. This lasts only for a few seconds to minutes. It is the very first vascular event, preceding the more prolonged period of vasodilation. 2. **Why the other options are incorrect:** * **Increased vascular permeability:** This occurs *after* vasodilation. It leads to the formation of inflammatory exudate (edema) and is a hallmark of acute inflammation, but it is not the earliest event. * **Phagocytosis:** This is a cellular event involving neutrophils and macrophages. It occurs much later in the inflammatory cascade, following margination, rolling, adhesion, and transmigration. * **Apoptosis:** This is a form of programmed cell death. While it is a response to certain types of injury, it is a complex pathway involving gene activation and caspase cascades, not an immediate vascular manifestation. **NEET-PG High-Yield Pearls:** * **Sequence of Vascular Changes:** Transient Vasoconstriction → Persistent Vasodilation (causing heat/redness) → Increased Permeability (causing swelling) → Stasis → Leukocyte Margination. * **Lewis Triple Response:** If the injury is a skin stroke, the sequence is: Flush (capillary dilation), Flare (arteriolar dilation), and Wheal (exudation/edema). * **Most Common Mechanism of Permeability:** Endothelial cell contraction (leads to "interendothelial gaps"), primarily affecting post-capillary venules. [1] Note: While cellular swelling is the first morphologic manifestation of cellular injury itself [1], in the context of vascular responses to injury, transient vasoconstriction is the initial event. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 51-53.

Question 480: In individuals who donate one lobe of the liver for transplantation, the remaining organ soon grows back to its original size. This is an example of which adaptive mechanism?

A. Hypertrophy
B. Atrophy
C. Hyperplasia (Correct Answer)
D. Metaplasia

Explanation: **Explanation:** The correct answer is **Hyperplasia**. **Why it is correct:** Liver regeneration following a partial hepatectomy (or lobe donation) is a classic example of **Compensatory Hyperplasia** [1]. In this process, the remaining hepatocytes exit the $G_0$ phase of the cell cycle and enter mitosis to restore the functional mass of the organ [4]. This is driven by growth factors (like HGF and TGF-$\alpha$) and cytokines (like IL-6 and TNF) [1]. Unlike true regeneration where lost structures are replaced, the liver restores its original *mass* rather than its original *shape* [2]. **Why other options are incorrect:** * **Hypertrophy:** This refers to an increase in the **size** of cells, leading to an increase in organ size [5]. While some hypertrophy occurs in the liver, the primary mechanism for restoring mass is the proliferation of new cells (hyperplasia). * **Atrophy:** This is the shrinkage in cell size or number, leading to a decrease in organ size. It is the opposite of what occurs after liver donation. * **Metaplasia:** This is a reversible change where one adult cell type is replaced by another (e.g., Squamous metaplasia in a smoker's airway). It does not involve an increase in organ mass. **High-Yield Clinical Pearls for NEET-PG:** * **Liver Regeneration:** The liver is the only internal organ capable of such extensive regeneration. It can restore up to 70% of its mass within weeks [3]. * **Hyperplasia vs. Hypertrophy:** Remember that tissues with "labile" or "stable" cells (like liver, skin, or GI tract) undergo hyperplasia [5]. Permanent cells (like cardiac muscle or neurons) can only undergo hypertrophy. * **Physiological Hyperplasia:** Can be **Hormonal** (e.g., breast enlargement during puberty/pregnancy) or **Compensatory** (e.g., liver regeneration) [5]. * **Pathological Hyperplasia:** Often a precursor to cancer (e.g., Endometrial hyperplasia), except for Benign Prostatic Hyperplasia (BPH), which does not increase cancer risk [5]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 113-115. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 113. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 108-109. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 87-88. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-87.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free